All the news Showing 10 of 975 articles from: Hepatitis CGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources First vaccine for viral hepatitis C could become a reality Eurekalert Inf Dis / 01 April 2011 Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189 Pipeline Review / 01 April 2011 'Fantastic' data on Novartis' first-in-class hep C antiviral Pharma Times / 01 April 2011 Well-known statin could be recycled as HCV therapy supplement EASL / 01 April 2011 EASL Clinical Practice Guidelines: Management of Hepatitis C Virus Infection EASL / 31 March 2011 Results From Phase 3 REALIZE Study Showed Telaprevir-Based Therapy Significantly Improved SVR (Viral Cure) Rates in People Whose Prior Treatment For Hepatitis C Was Unsuccessful Business Wire / 31 March 2011 Interim Phase 2 Data Showed Rapid Viral Response to VX-222 in Combination with Telaprevir, Pegylated-Interferon and Ribavirin Among People With Hepatitis C Business Wire / 31 March 2011 UCLA study finds cholesterol regulator plays key role in development of liver scarring, cirrhosis Eurekalert Medicine & Health / 30 March 2011 Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor Business Wire / 30 March 2011 Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes PR Newswire / 30 March 2011 ← Prev1...9394959697...98Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds